These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 38213239

  • 41. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions.
    Karavas E, Ktistis G, Xenakis A, Georgarakis E.
    Drug Dev Ind Pharm; 2005 Jul; 31(6):473-89. PubMed ID: 16109621
    [Abstract] [Full Text] [Related]

  • 42. Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation.
    Swain RP, Subudhi BB.
    Drug Dev Ind Pharm; 2018 Jan; 44(1):56-65. PubMed ID: 28845687
    [Abstract] [Full Text] [Related]

  • 43. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
    Liu C, Desai KG.
    Pharm Dev Technol; 2005 Jan; 10(4):467-77. PubMed ID: 16370176
    [Abstract] [Full Text] [Related]

  • 44. Electrospun emodin polyvinylpyrrolidone blended nanofibrous membrane: a novel medicated biomaterial for drug delivery and accelerated wound healing.
    Dai XY, Nie W, Wang YC, Shen Y, Li Y, Gan SJ.
    J Mater Sci Mater Med; 2012 Nov; 23(11):2709-16. PubMed ID: 22875606
    [Abstract] [Full Text] [Related]

  • 45. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK.
    Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
    [Abstract] [Full Text] [Related]

  • 46. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A, Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi A.
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [Abstract] [Full Text] [Related]

  • 47. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A, Cavallari C, Ospitali F.
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [Abstract] [Full Text] [Related]

  • 48. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K, Yoo YJ.
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
    [Abstract] [Full Text] [Related]

  • 49. Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions.
    Mallick S, Sahoo A, Mitra SS.
    Boll Chim Farm; 2003 May; 142(4):180-6. PubMed ID: 12918228
    [Abstract] [Full Text] [Related]

  • 50. In vitro dissolution and physicochemical characterizations of novel PVP-based solid dispersions containing valsartan prepared by a freeze-drying method.
    Xu WJ, Liu Y, Shi LL, Cui JH, Cao QR.
    Pak J Pharm Sci; 2014 Nov; 27(6):1799-804. PubMed ID: 25362604
    [Abstract] [Full Text] [Related]

  • 51. Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment.
    Colombo M, de Lima Melchiades G, Michels LR, Figueiró F, Bassani VL, Teixeira HF, Koester LS.
    AAPS PharmSciTech; 2019 Feb 11; 20(3):106. PubMed ID: 30746582
    [Abstract] [Full Text] [Related]

  • 52. Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems.
    Koh PT, Chuah JN, Talekar M, Gorajana A, Garg S.
    Indian J Pharm Sci; 2013 May 11; 75(3):291-301. PubMed ID: 24082345
    [Abstract] [Full Text] [Related]

  • 53. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel.
    Chen J, Qiu L, Hu M, Jin Y, Han J.
    Drug Dev Ind Pharm; 2008 Jun 11; 34(6):588-94. PubMed ID: 18568908
    [Abstract] [Full Text] [Related]

  • 54. Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability.
    Zhang F, Mao J, Tian G, Jiang H, Jin Q.
    AAPS PharmSciTech; 2022 Jan 31; 23(1):65. PubMed ID: 35102461
    [Abstract] [Full Text] [Related]

  • 55. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
    Yang M, He S, Fan Y, Wang Y, Ge Z, Shan L, Gong W, Huang X, Tong Y, Gao C.
    Int J Pharm; 2014 Nov 20; 475(1-2):97-109. PubMed ID: 25171976
    [Abstract] [Full Text] [Related]

  • 56. Preparation and characterization of cefuroxime axetil solid dispersions using hydrophilic carriers.
    Gorajana A, Rajendran A, Yew LM, Dua K.
    Int J Pharm Investig; 2015 Nov 20; 5(3):171-8. PubMed ID: 26258059
    [Abstract] [Full Text] [Related]

  • 57. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
    Zhao X, Liu X, Gan L, Zhou C, Mo J.
    Arch Pharm Res; 2011 Jun 20; 34(6):949-59. PubMed ID: 21725816
    [Abstract] [Full Text] [Related]

  • 58. Formulation and in vivo hypoglycemic effect of glipizide solid dispersion.
    Patel GC, Asodaria KV, Patel HP, Shah DR.
    Curr Drug Deliv; 2012 Jul 20; 9(4):395-404. PubMed ID: 22640037
    [Abstract] [Full Text] [Related]

  • 59. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
    Shi X, Xu T, Huang W, Fan B, Sheng X.
    AAPS PharmSciTech; 2019 Mar 18; 20(4):143. PubMed ID: 30887265
    [Abstract] [Full Text] [Related]

  • 60. Preparation, Characterization and Stability Studies of Glassy Solid Dispersions of Indomethacin using PVP and Isomalt as carriers.
    Khodaverdi E, Khalili N, Zangiabadi F, Homayouni A.
    Iran J Basic Med Sci; 2012 May 18; 15(3):820-32. PubMed ID: 23493157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.